Skip to main content
Home
Company
About Us
Executive Team
Board of Directors
Scientific & Clinical Advisors
Partners
Technology
Multi-Cytokine Inhibitor Platform
Itolizumab
Publications
Presentations
Clinical
Pipeline
Clinical Studies
Expanded Access Policy
Investors
Investor Overview
Stock Information
Stock Chart
Analyst Coverage
Press Releases
Events & Presentations
Email Alerts & Contacts
SEC Filings
Corporate Governance
Governance Documents
Committee Composition
Investor FAQs
Careers
Contact Us
Search query
Contact Us
Equillium, Inc. (Headquarters)
2223 Avenida De La Playa, Suite 105
La Jolla, California 92037
858-240-1200
Company Contacts
General Contact
[email protected]
Investor Inquiries
[email protected]
Patient Advocacy Inquiries
[email protected]
Media Inquiries
[email protected]
Medical Information
[email protected]
Career Inquiries
[email protected]
Clinical Trial Information
[email protected]